Corcept Raises PIPE

Corcept Therapeutics Inc. (Nasdaq: CORT) has raised $10.1 million in PIPE funding. Paperboy Ventures led the deal, and was joined by fellow existing Corcept shareholders Sutter Hill Ventures and Alta Partners. Corcept is a Menlo Park, Calif.-based drug company focused on psychiatric and neurological diseases. www.corcept.com